Clinical Trials Arena May 13, 2022
Clinical Trials Arena demystifies how AI can potentially help participants stick to the study all the way to the end, while also pointing to clinical trial sponsor blind spots.
Clinical trial participants adhering to the study protocol and the risk of patients dropping out are key concerns among study sponsors. Current ways to avoid these scenarios often involve labour-intensive tasks. If efforts to avoid these concerns are unsuccessful, they can lead to study failure.
With such concerns, the potential of artificial intelligence (AI) intrigues the clinical trials industry. However, there are still reservations, such as the fear that AI could be a Pandora’s box, unleashing unnecessary risks to clinical trial completion.
One key concern is...
Today's Sponsors
Today's Sponsor